Genomictree Inc.
228760
Rank in Stocks
#19094
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Share Price
$6.67
Market Cap
$163.62M
Change (1 day)
0.73%
Change (1 year)
-49.61%
Country
KR
Trade Genomictree Inc. (228760)
Category
Healthcare
Stock split history for Genomictree Inc. (228760)
Genomictree Inc. stock (symbol: 228760) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One 228760 share bought prior to Oct 21, 2026 would equal to 0 228760 shares today.
The most recent stock split occurred on Oct 21, 2026.
One 228760 share bought prior to Oct 21, 2026 would equal to 0 228760 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
